Search peptides, terms, sources/
Research source · 2016

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (LEADER)

About this source

Kind
Research
Design
Human clinical trial, RCT
Population
Adults with type 2 diabetes, high cardiovascular risk
Primary or secondary
primary
Retraction status
None known
Date checked
14 August 2026

Limitations

Sponsor-funded. Population was people with type 2 diabetes, not a general weight-management group.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.